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ABSTRACT

ARTICLE HISTORY

The COVID-19 pandemic affected the lives of people living across the world and the development of
vaccines against SARS-CoV-2 is considered to be one of the most promising solutions to contain the
COVID-19 pandemic. In several countries, we are witnessing hesitancy toward COVID-19 vaccines, which is
a complex phenomenon influenced by a variety of factors. A cross-sectional study was performed to
comprehensively investigate the impact of factors like demography, COVID-19 pandemic-induced beha
vior, and vaccine attitude on COVID-19 vaccine acceptance (VA) among communities of five different
universities in the United Arab Emirates (UAE). To investigate the effect of demography and COVID-19
pandemic-induced behavioral factors, Analysis of Variance was perfomed. The effect of COVID-19 vaccine
attitudes on COVID-19 VA was examined through partial least squares-structural equations modeling. The
results of the study showed no difference among the population in accepting COVID-19 vaccines due to
their demographic factors. The effect of pandemic-induced behavioral factors on COVID-19 VA suggested
that the people of UAE accepted COVID-19 vaccines irrespective of the movement and travel restrictions
imposed due to the pandemic. The results on the effect of vaccine attitudes on COVID-19 VA showed that
vaccine benefit attitudes, safety concerns, and trust in health-care professionals (TrHP) were found to be
significant factors in VA. Furthermore, TrHP was found to reduce the negative effect of safety concerns
related to COVID-19 VA. The findings broadly highlight that COVID-19 VA in the UAE was not hampered by
demographic factors and the pandemic-induced behavioral constraints. The study also showed that
people with co-morbidities had lower level of COVID-19 VA than people with no co-morbidities. To
improve COVID-19 VA, the perceived benefits with COVID-19 vaccine and TrHP must be enhanced and
simultaneously safety concerns of the vaccines need to be addressed.
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Introduction
The COVID 19 pandemic has affected the lives of people across
the world. It has necessitated countries to impose movement
and travel restrictions, which resulted in economic and social
isolation of economies.1 The SARS-CoV-2 disease 2019
(COVID-19) pandemic was reported to have started during
the end of 2019 and since the year 2021, many COVID-19
vaccines have been made available globally. These vaccines
varied in terms of their mechanism of action to protect against
the SARS-CoV-2 by reducing the severity of its signs and
symptoms in the vaccinated individuals.2,3 The virus has
fewer opportunities to mutate if its spread is restricted.4
Globally, millions of people are still hesitating to take the
COVID-19 vaccine.5–7 Around the globe, medical care systems
are trying to establish public conviction on validity and safety
of the COVID-19 vaccines, but regrettably the hesitancy of
getting the vaccine still persists.8 The rate of vaccination
against COVID-19 is still very low across several countries, as
only 57.8% of global population was fully vaccinated until
March 2022.9 Low vaccination rates result in increase in the
emergence of new variants of COVID-19 virus.10 The new
variant of SARS-CoV-2, Omicron was identified in Africa
wherein only 11% of population was fully vaccinated until
CONTACT Ayisha Siddiqua
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February 2022.11,12 It is the responsibility of all countries across
the world to vaccinate their residents and control the emer
gence of new variants and their spread. This also necessitates
the policymakers to learn from countries that are successful in
COVID-19 vaccination programs to enhance their own vacci
nation programs.
The UAE is the second country in the world after British
Overseas Territory of Gibraltor to achieve the milestone of
highest rate of COVID-19 vaccination in the world.9 Until
March 2022, around 96.97% of the eligible UAE population
was doubly vaccinated and 100% of the eligible UAE popula
tion had received a single dose.13 This milestone is considered
to be highly significant due to the fact that the population size
of Gibraltor is very small (around 33,000) in comparison to
UAE, which has a population of more than 9.8 million.9 Even
though, the COVID-19 vaccination program has been success
ful in the UAE, there are limited number of research studies
that have investigated the factors contributing to such
a massive acceptance of COVID-19 vaccine. Albahri et al.
studied COVID-19 vaccine acceptance among general adult
population in the UAE.14 Elbarazi et al. conducted
a qualitative study for exploring COVID-19 vaccine hesitancy
among health-care providers in the UAE.15 Alsuwaidi et al.
investigated the determinants of vaccine hesitancy among Arab
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parents in the UAE.16 Ahamed et al. conducted a study to
understand the perception of Sinopharm vaccine in the
UAE.17 The purpose of our study is to investigate the demo
graphic, behavioral, and attitudinal factors affecting COVID19 VA among communities of different universities in the
UAE. There has been no other study conducted that has com
prehensively investigated the effects of all these factors that
influence the COVID-19 VA among communities of different
universities in the UAE. COVID-19 VA has been examined in
different contexts and several studies have investigated the
effects of demographic variables, such as gender, age, educa
tion, occupation, and nationality.18–21 The pandemic-induced
behavioral constraints, such as movement and travel restric
tions for the individuals who are not vaccinated are considered
to be important factor toward the implemenation of COVID19 vaccination programs.22–24 Previous studies in COVID-19
VA have examined the effects of attitudinal variables, such as
benefit attitudes,25–27 safety concerns25,27,28 and trust in healthcare professionals.6,28

Methods
A cross-sectional survey among students, staff, and parents
who are 18 years and above from five different educational
institutions in the UAE was conducted using online survey
questionnaire. The online survey was conducted during the
period from January 2021 till mid June 2021. The university
communities included in the study were students, staff, and
parents. The parents were also considered as part of the uni
versity community in this study as they follow the progress of
their wards’ education and the universities are required to
coordinate with parents for overall development of the
students.29
The questionnaire measured four aspects; (a)
COVID−19 pandemic-induced behavioral factors that
would influence VA; (b) attitudes toward COVID-19 vac
cine; (c) COVID-19 VA; (d) demographic factors that
influence acceptance of COVID-19 vaccine. The attitudi
nal factors, such as SaCn, BeAtt and TrHP and VA are
measured using the measures used in the previous vacci
nation studies. The measures include 7-point (1 – strongly
disagree and 7 – strongly agree) multi-item Likert scale
statements to measure each of the above-mentioned atti
tudinal constructs. The vaccine hesitancy/acceptance was
measured by the scale used by Shapiro et al. 30 TrHP
construct was measured by the scale used by Karlsson
et al.31 The SaCn and BeAtt were measured by the scale
used by Cataldi et al. 32 This questionnaire has been
reviewed and approved according to Zayed University
procedures of research involving human-related subjects.
It was also approved by the Ministry of Health and
Prevention Research Ethics Committee Reference No:
MOHAP/DXB-REC/JFF/No.06/2021.
The findings of our study would serve as a guide to research
ers and policymakers across the world to devise their COVID19 vaccination programs effectively. The demographic factors
explored are gender, age, education level, nationality, and
marital status. The effect of COVID-19 pandemic-induced

behavioral factors on VA, such as movement restriction
between cities, restrictions on international travel, work from
home for employees and online classes for students was inves
tigated. In addition, role of other behavioral factors, such as
prior vaccination and co-morbidity health status, were
explored. The role of attitudinal factors, such as benefit atti
tudes toward COVID-19 vaccine (BeAtt), safety concerns
toward COVID-19 vaccine (SaCn) and trust in health-care
professional (TrHP) in VA were investigated. Furthermore,
the study examined the moderation effect of TrHP in the
association of BeAtt and SaCn on VA.
The questionnaire was prepared both in English and Arabic
language. The questionnaire was first prepared in English,
which was translated into Arabic language by an expert. The
Arabic language questionnaire was then independently back
translated to English by another expert. The inconsistencies in
the Arabic language questionnaire were removed through con
sultations. The questionnaire was created in Microsoft Forms
that has the provision of both English and Arabic versions and
the respondent could choose to respond in any of the versions
of the questionnaire. The link of questionnaire was e-mailed to
the students, staff, and parents. The respondents selfadministered the questionnaire and answered the questions.
We used purposive and convenience sampling method to select
the respondents. For the respondents in the category of par
ents, the questionnaire link was sent to the students and these
students were requested to help their parents to fill the ques
tionnaire. Inclusion criteria used in the study was that the
respondents were required to be part of any of the above
mentioned groups. The respondents whose age was less than
18 years and the respondents who did not agree to be part of
the study were excluded from the study. Assuming a vaccine
acceptance of 50% in February 2021 with a marign of error of
3% (95% confidence interval 47%–53%), the minimum sample
size calculated for the study was 1067 using the formula33
below mentioned:
N¼

Pð100% PÞ
ðSEÞ2

N-Sample size; P-Estimated percentage; SE-Standard Error

Statistical analysis
We used two statistical technques to analyze the collected data.
To analyze the effect of demographic and pandemic-induced
behavioral factors on VA, we used analysis of variance
(ANOVA) through IBM SPSS. The ANOVA is used to test
the difference in the means of two or more groups of a sample.
The ANOVA is a useful technique to investigate the relation
ship between categorical independent variables and
a dependent variable that is measured on an interval scale.
The equation34 for ANOVA is mentioned below:
SSy ¼ SSx þSSe
SSy denotes total variation in dependent variable, Y.
SSx denotes the variation in Y related to the variation in the
means of groups of independent variable, X.
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Figure 1. Partial least squares path modeling with latent variables.

SSe denotes the variation within each group of X but not
accounted for by independent variable, X.
To examine the effect of attitudinal constructs, such as BeAtt,
SaCn, and TrHP on VA, partial least squares structural equa
tions modeling (PLS-SEM) through SmartPLS 3.0 was used. The
attitudinal and vaccine acceptance constructs are measured
using multi-item scales and these constructs are considered to
be latent variables. PLS-SEM is an appropriate tool to assess the
measurement properties of these latent variables and the struc
tural relationship between these variables.35 PLS-SEM draws
both measurement and structural models. By using weighted
sum of all items, the measurement model estimates each con
struct used in the study.36 The results of measurement model
produces statistics to evaluate the measurement properties of the
measured latent variables. The structural model shows the rela
tionship between dependent and independent variables through
multiple linear regressions.36 The model for PLS-SEM36 is pre
sented in Figure 1 with two latent variables as an example and
their indicators.
Y1 and Y2 are latent variables that are measured by their
respective indicators (items) denoted as x1, x2 . . . x6. Y2 is
a dependent latent variable and Y1 is indepdent latent variable
and has an error term z1 and z2 respectively. The strength of the
relationship between Y1 and Y2 is represented by a path coeffi
cient, b1. The strength of the relationship between x1, x2, x3 . . .
x6 is represented by factor loading l1, l2, l3 . . . l6 respectively. e1,
e2, e3 . . . .e6 represents random measurement error.

Results
Sample characteristics and analysis of the effect of
demographic factors
The study reported responses from 2021 respondents, out of
which 77 respondents declined to participate in the study. Two
hundred and ninety-one respondents were under the age of 18
years and were not allowed to participate in the study. As
a result, the sample size was 1,653 with a response rate of 81.79%.
The collected data was first analyzed to understand the
sample characteristics, which are presented in Table 1. The
majority (81.67%) of the respondents filled in the English
version of the questionnaire. Most of the respondents
(64.85%) were students and the majority (80.04%) of the
respondents were female. Most (68.12%) of the respondents
were in the age category of 18–25 years. In regard to the
education status of the respondents, high-school education
and undergraduate education were the major categories with

Table 1. Sample characteristics and effect of demographic factors.
Dependent variable: Vaccine Acceptance
Demographic factors
No. of
(Independent variables) respondents Percentage Mean F-Value p-Value
Language of the respondents
English
1350
81.67
Arabic
303
18.33
Category of university communities
Student
1072
Staff
78
Parent
503

64.85
4.72
30.43

53.26
55.81
53.87

1.63

0.20

Gender
Male
Female

330
1323

19.96
80.04

54.11
53.43

0.74

0.39

1126
242
172
79
34

68.12
14.64
10.41
4.78
2.06

53.37
53.29
55.03
54.20
53.03

0.71

0.59

40
659
196
599
159

2.42
39.87
11.86
36.24
9.62

48.70
54.24
54.05
53.02
53.43

2.226

0.06

1378
61
93
121

83.36
3.69
5.63
7.32

53.74
52.79
51.49
53.52

0.961

0.41

Age
18 to 25 Years
26 to 35 Years
36 to 45 Years
46 to 55 Years
56 Years or More
Education
None
High school
Diploma
Undergraduate
Postgraduate
Nationality
UAE
Other GCC
Arab
Others

39.87% and 36.24%, respectively. The majority (83.36%) of the
respondents were UAE nationals and most of the respondents
(68.20%) showed marital status as “single”.
The effect of demographic and COVID-19 pandemicinduced behavioral factors on COVID-19 VA was investi
gated by the Analysis of Variance (ANOVA) using IBM
SPSS. The VA score of the respondents was computed
with the summation of all the reliable and valid items
and the summated VA score was used as dependent vari
able. Table 1 also shows the results of ANOVA regarding
the effect of different demographic factors that would
influence VA. The results establish that the demographic
factors, such as the category of university community
(F-value = 1.20; p-value = .31), gender (F-value = .74;
p-value = .39), age (F-value = .71; p-value = .59), and
nationality (F-value = .96; p-value = .41) play no role in
VA in the UAE. However, education level was found to
have an effect on the VA (education level (F-value = 2.226;
p-value = .06)).
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Effect of COVID-19 pandemic-induced behavioral factors
The results of the analysis of the effects of COVID-19
pandemic-induced behavioral factors on COVID-19 VA is
shown in Table 2. Behavioral factors such as mode of
classes for the students (F-value = .78; p-value = .51), mode
of work for the employed (F-value = .76; p-value = .47), and
vaccination before international travel (F-value = 1.66;
p-value = .16) were found to not affect COVID-19 VA in
the UAE. However, the behavioral factors, such as planned
international travel for the next one year (F-value = 11.30;
p-value = .00) and travel in and out of Abu Dhabi emirate
(state) (F-value = 4.95; p-value = .00) were found to have
a significant effect on VA in the UAE. Interestingly, the
means of VA of the respondents who did not have inter
national travel plans and the respondents who did not
move in and out of Abu Dhabi emirate were higher than
the means of VA of the respondents who had plans for
international travel and who moved in and out of Abu
Dhabi emirate. The presence of co-morbid diseases
(F-value = 10.65; p-value = .00) was found to significantly
affect VA. Surprisingly, means of VA of people who did
not have co-morbid diseases were significantly higher than

Table 2. Analysis of behavioral factors - analysis of variance (ANOVA).
COVID 19 Pandemic-induced
behaviour factors (independent
variables)
Mode of classes for students
Face-to-face classes
Online classes
Blend of face-to-face and online
classes
No classes
Mode of work for employed
Go to the office physically
Work from home
Combination of both the above
International travel for next year?
Yes
No
Travel in and out of Abu Dhabi emirate?
Yes
No
Flu vaccine frequency in the past?
Twice every year
Once every year
I almost take the flu vaccines every 2
years
I took the flu vaccine only once
previously
Never
Vaccination before international travel?
Yes, every time
Almost every time
Only when I travel to Mecca or some
countries in South Asia
Once or twice only
Never
Co-morbidity diseases for Covid-19?
Yes
No
Vaccinated for Covid-19?
Yes
No

Dependent variable: Vaccine
acceptance
No. of
respondents Mean F-Value p-Value
43
844
237

50.33
53.24
53.65

0.78

0.51

23

53.22

185
297
218

55.41
54.00
54.85

0.76

0.47

556
1,097

52.07
54.32

11.30

0.00

561
1,092

52.58
54.07

4.95

0.03

91
343
120

50.25
57.04
51.89

13.70

0.00

470

54.82

629

51.53

137
115
303

53.78
53.29
54.70

179
915

54.85
52.91

267
1,386

51.21
54.02

1,064
589

1.66

0.16

10.65

0.00

57.09 258.90
47.19

0.00

the people who had co-morbid diseases. Previous flu vacci
nation frequency (F-value = 13.70; p-value = .00) was found
to have a significant effect on VA in the UAE. Furthermore,
COVID-19 vaccination was found to significantly affect
(F-value = 258.90; p-value = .00) VA and the mean of VA
of vaccinated respondents was significantly higher than the
non-vaccinated respondents.
Effect of COVID-19 vaccine benefit attitudes
To test the effects of COVID-19 vaccine attitudes on COVID-19
VA, partial least squares-structural equations modeling (PLSSEM) using SmartPLS 3.0 software37was performed. The results
of PLS-SEM were assessed on two important aspects, such as the
measurement model and the structural model. The measurement
model validates the reliability and validity of the scales used in the
study and the structural model evaluates the significance of the
effects of independent variables on the dependent variable.
Measurement model
Tables 3 and 4 show the results of the measurement model of
the study. Table 5 explains the structural model of the study.
Table 3 lists all the items used to measure the constructs such as
safety concerns (SaCn), benefit attitudes (BeAtt), trust in
health-care professionals (TrHP), and COVID-19 VA.
Table 3 also shows the loading of each item of each construct
with their respective constructs with loading more than .50 and
the lesser loading of the items with other constructs.38 The
items with less factor loading and higher cross-loading were
removed from the study. The results shown in Table 3 indicate
a satisfactory convergent and discriminant validity of the scales
used in the study.
Table 4 shows the reliability and validity of the scales used in
the study. Reliability was established by Cronbach’s Alpha and
composite reliability that was found to exceed the minimum
cutoff of .70.38 Convergent validity was established by Average
Variance Extracted (AVE). AVEs of all the four constructs used
in the study exceeded the cutoff of .50, establishing satisfactory
convergent validity. The discriminant validity was established
by Fornell and Larcker’s criterion of the square root of AVEs
and should be more than inter-construct correlations.38 The
diagonal values in Table 4 are the square root of the respective
constructs, which were found to be more than its correlation
with other constructs. This result established satisfactory dis
criminant validity of the measures of the study.
Structural model
Table 5 shows the results of two PLS structural models, the first
is main effects model and the second is moderation effects
model. In the main effects model, BeAtt, SaCn, and TrHP
were included as independent variables with VA as the depen
dent variable. Both the structural models were first assessed for
explanatory power through the R2 value, which is supposed to
be more than .40 for a satisfactory explanatory power.38 The
main effects model produced R2 value of .39 and the modera
tion effects model produced R2 of .40 and hence shows the
satisfactory explanatory power of both the models. It means
that 39% and 40% of the variance in the dependent variable,
VA is explained by the independent variables used in the main
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Table 3. Outer loadings and cross-loadings.
Indicators/Constructs
The benefit of the COVID-19 vaccine (BeAtt)
BEA1. Good hygiene will make COVID-19 disappear from society–the vaccine is not necessary (R)
BEA2. Good hand hygiene and other preventive efforts are enough for avoiding the COVID-19 even without vaccination (R)
BEA3. It is not worth getting the COVID-19 vaccine, as the COVID-19 symptoms are not serious (R)
BEA4. I do not need a vaccine for COVID-19 as it’s a temporary disease (R)
Safety concern of COVID-19 vaccine (SaCn)
SC1. I believe there has not been enough research on the safety of COVID-19 vaccines
SC2. I believe that my immune system could be weakened by COVID-19 vaccines
SC3. I am concerned that the ingredients in COVID-19 vaccines are unsafe
SC4. I am concerned that COVID-19 vaccines have serious side effects
SC5. As COVID-19 vaccines are new, I am not sure about taking it

BeAtt

SaCn

TrHP

VA

.78
.76
.85
.86

−.45
−.45
−.50
−.60

−.03
−.05
0.06
0.10

0.27
0.26
0.38
0.46

−.43
−.59
−.40
−.43
−.54

.72
.77
.77
.78
.83

0.05
0.01
0.03
0.04
−.03

−.24
−.33
−.30
−.24
−.39

Trust in healthcare professionals (TrHP)
Tr 1. When healthcare professionals make medical decisions, they have the patients’ best interest in mind
Tr 2. Parents/patients should leave the decisions that concern their or their children’s health in the healthcare professionals’ hands
Tr 3. Doctors need to be authoritative toward their patients for optimum care

0.11
−.09
0.05

0.01
0.09
−.03

.84
.75
.80

0.38
0.25
0.35

COVID-19 Vaccine Acceptance (VA)
VA1. COVID-19 vaccines are important for my health
VA2. COVID-19 vaccines are effective
VA3. All COVID-19 vaccines offered by the government program in UAE are beneficial.
VA4. Getting the vaccine is a good way to protect myself from COVID-19.
VA5. Generally, I do what my doctor or healthcare provider recommends about COVID-19 vaccines.
VA6. The information I receive about COVID-19 vaccines from the vaccine program is reliable and trustworthy.
VA7. Having myself vaccinated for COVID-19 is important for the health of others in my community
VA8. Everyone must get vaccinated for COVID-19 once the vaccine is available
VA9. COVID-19 vaccination should be compulsory for everyone
VA10. Those who are not COVID-19 vaccinated are risking their health or the health of their family
VA11. I am motivated to get the COVID-19 vaccine when I see some influential leaders/celebrities getting vaccinated

0.37
0.29
0.31
0.41
0.32
0.32
0.40
0.44
0.20
0.38
0.16

−.35
−.30
−.28
−.33
−.26
−.25
−.29
−.37
−.31
−.35
−.25

0.32
0.33
0.35
0.31
0.36
0.38
0.35
0.32
0.27
0.28
0.24

.83
.77
.77
.86
.77
.71
.81
.83
.67
.78
.59

Table 4. Construct reliability and validity.
Inter-construct correlations
Constructs
Benefit of COVID-19 vaccine (BeAtt)
Safety concern of COVID-19 vaccine (SaCn)
Trust in healthcare professionals (TrHP)
COVID-19 Vaccine Acceptance (VA)

Cronbach’s Alpha
0.84
0.83
0.71
0.93

Composite Reliability
0.89
0.88
0.84
0.94

AVE
0.66
0.60
0.63
0.59

BeAtt
.81
−.62
0.05
0.44

SaCn

TrHP

VA

.77
0.02
−.40

.80
0.42

.77

AVE-Average variance extracted. Values in the diagonal are the square root of respective construct’s AVEs and they are in a bold highlight and show that these values are
more than respective construct’s inter-correlations with other constructs.

Table 5. Results of PLS structural models.
Dependent variable: Vaccine Acceptance
Main effects model
Independent variables
Benefit of COVID-19 vaccine (BeAtt)
Safety concern of COVID-19 vaccine (SaCn)
Trust in healthcare professionals (TrHP)
TrHP X BeAtt
TrHP X SaCn
R2
Q2

Std. path co-efficients
0.27
−.23
0.41
0.39
0.222

Moderation effects model
t-value
11.05*
8.35*
14.23*

Std. path co-efficients
0.28
−.22
0.38
−.06
−.14
0.40
0.232

t-value
10.95*
7.72*
14.40*
1.87
4.46*

* p value <.01 level; ** p value <.05 level.

effects model and moderation effects model, respectively. The
structural models were assessed for predictive relevance by
Q2value, which was produced by following the blindfolding
approach available in SmartPLS 3.0.38 The Q2 is supposed to be
more than zero for a satisfactory predictive relevance. In both
main effects (.222) and moderation effects (.232) model, it
exceeded zero which establishes satisfactory predictive
relevance.38 Furthermore, the structural model was assessed
for predictive power by assessing the significance of path coef
ficients. The independent variables, such as BeAtt and TrHP

were found to have a significant positive effect on VA (path
coefficient for BeAtt = .27 with p-value <.01 level; path coeffi
cient for TrHP = .41 with p-value <.01 level). The SaCn was
found to have a negative effect on VA (path coefficient for
SaCn = > −.23 with p-value <.01 level).
In the moderation effects model, the moderation effect of
TrHP in association with BeAtt and SaCn on VA was tested.
The results suggested that in the presence of TrHP, negative effect
of SaCn on VA was significantly reduced (moderation effect path
coefficient for SaCn = > −.14 with p-value <.01 level). However,
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the moderation effect of TrHP was found to have no impact on
the effect of benefits perception on VA (moderation effect path
coefficient for BeAtt = > −.06 with non-significant p-value).

Discussion
This study investigated the role of demographic, COVID-19 pan
demic-induced behavioral and attitudinal factors in the acceptance
of COVID-19 vaccine among communities of different universi
ties in the UAE. The results of the study suggested that the demo
graphic factors, such as category of university community, age,
gender, and nationality did not play a role in the acceptance of the
COVID-19 vaccine. These results imply to the policymakers that
the COVID-19 pandemic situation necessitated the people to
accept the COVID-19 vaccination irrespective of the category of
community in the society, age level, gender, or nationality. This is
considered to be a highly welcoming phenomenon for COVID-19
vaccination program in the UAE that the communities of different
universities in the UAE embraced the COVID-19 vaccination
program without any major reservations irrespective of variation
in demographic factors. Previous studies that investigated the
effect of demographic factors on VA showed mixed results. For
example, in regard to effect of age, Martin et al.,20 Malik et al.21 and
Skjefte et al.28 found that the elderly individuals were found to have
higher VA than the younger. In contrast, Harapan et al.19 and Solís
Arce et al.39 found no difference in VA between different age
groups. With respect to the effect of gender on VA, previous
studies found mixed results. Dror et al.,5 Solís Arce et al.,39 Kreps
et al.40 and Shekar et al.41 found higher levels of VA among males
than females. Schernhammer et al., which studied vaccine hesi
tancy in Austria found that it was higher in females and young
adults.42 Our finding is consistent with Syed Alwi et al.18 and
Harappan et al.19 who found no effect of gender on COVID-19
VA. Our study found a significant effect of education level on VA.
The respndents who had no formal education were found to have
lower levels of VA than the respondents who had formal educa
tion. This finding is consistent with the results of Solís Arce et al.39
and El‑Mohandes et al.43 This finding implies that the policy
makers need to reach out to the group of people with lower levels
of education with appropriate messaging strategies.39 Lim et al.
studied vaccine acceptance in a university amongst students and
found that many students were still hesistant to take vaccines.44
The results regarding COVID-19 pandemic-induced beha
vioral factors produced interesting findings. These findings
are unique and no previous studies on VA have examined
pandemic-induced behavioral factors on the VA. Kaufman
et al. did a qualitative study in prioritized adults, health, and
aged caretakers to take COVID-19 vaccines and observed
that adults had taken the vaccines so that they could travel
and not be in quarantine.45 It was expected that the beha
vioral factors, such as mode of classes for the students, mode
of work for the employees, travel restrictions, previous vac
cination behavior, and presence of co-morbidity would
enhance VA. About the mode of classes (whether online or
on-campus), the results suggested that this factor had no
effect on VA. A major consequence of the COVID-19 pan
demic was that the travel and movement of the people was

restricted for months. It was reasonably expected that if
people required the need for international travel and travel
between the emirates (states) within the UAE, they would
have higher VA than those who did not have any such
requirements. The results showed that the respondents who
were not traveling between the emirates showed more VA
than the travelers in between the emirates. Currently, travel
ing around the globe requires that people need to be vacci
nated. Many of the countries have foregone mandatory
quarantine periods for the people who are completely vacci
nated and this could have been the major cause for accepting
COVID-19 vaccines. It was expected that the respondents
who were planning to embark on international travel in the
next year would have more VA. On the contrary, the results
showed less VA among respondents who plan to embark on
international travel than those who had no such plans. These
results imply that international travel and movement restric
tions themselves do not lead to VA.
Flu vaccination frequency was considered to know whether
the respondents showed more COVID-19 VA due to higher flu
vaccination frequency. The results of the study supported our
expectations that previous flu vaccinations would enhance VA.
This finding is similar to other findings, which showed that
during the H1N1 pandemic, health-care workers who were
previously getting themselves vaccinated with influenza vac
cine were more receptive to the H1N1 vaccines.46 Pastorino
et al. also showed flu vaccination uptake resulted in increased
uptake of COVID-19 vaccines.47
The results regarding acceptance of COVID-19 vaccine
among people with co-morbid diseases showed that people
with co-morbidities had lower COVID-19 VA when com
pared to people without co-morbidities. Our findings are
not in agreement with the findings of Jiménez-Garcia et al.
who studied the acceptance of the influenza vaccine among
the diabetic population and observed that having chronic
diseases, such as chronic lung disease and previous uptake
of vaccine increased the vaccine acceptance.48 Increased
uptake of the vaccine was observed amongst co-morbid
patients when advised by health-care professionals and
when they had increased visits to health-care professionals.
Most of the time the refusal to take vaccine was the belief that
they were not at risk.48 Briggs et al. observed that older
patients’ acceptance of pneumococcal vaccine was very poor
as they had a very poor perception of their age.49 Our findings
are similar to a study conducted by Bödeker et al. regarding
influenza vaccination uptake in people with underlying
chronic diseases found that respondents who were above 60
years or who suffered from underlying chronic diseases
believed that influenza vaccination would result in
influenza.50 They observed that the most common reason
for poor VA was mistrust of vaccination and perception that
influenza was not dangerous.50 On the contrary, Serrazina
et al. who studied the VA in multiple sclerosis patients
found that the patients with co-morbidities were more willing
to take vaccines and found that one way to increase vaccine
acceptance was to involve physicians who would insist on
patients getting themselves vaccinated.51
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Regarding the effect of COVID-19 vaccine attitudes on
COVID-19 VA, the results suggested a significant positive
effect of benefit attitudes toward vaccine (BeAtt) and trust in
health-care professionals (TrHP) on VA. A study by Davis et al.
related to COVID-19 vaccine showed a similar finding that
enhancing the efficacy perception amongst population
increased the vaccine acceptance.52 The study found that the
safety concerns toward COVID-19 vaccine (SaCn) showed
a significant negative effect on VA. Even before the COVID19 vaccines were rolled out by various companies, vaccine
hesitancy related to safety concerns was an issue.
Almaghaslah et al. identified that even though the participants
were aware of the likelihood of getting the infection, the effi
cacy and safety of the vaccine were considered as barriers to
vaccination.53 Alabdulla et al. found that while studying vac
cine hesitancy in Qatar, a substantial population was not ready
to get vaccinated, especially the females.54 The reasons cited for
not accepting the vaccine were concerns around the safety of
the COVID-19 vaccine and its long-term side effects.
Schernhammer et al. observed that trust in government was
very important for COVID-19 vaccine acceptance.42
In our study, the moderation effect of TrHP in the associa
tion of BeAtt and SaCn with COVID-19 VA was assessed. Our
results showed that the TrHP reduced the effect of SaCn on VA
while the TrHP did not impact the effect of BeAtt on VA. This
is an interesting finding that could lead to major policy-level
implications. This finding re-emphasizes the importance of
enhancing TrHP as it directly improves the level of VA and
further reduces the negative effect of SaCn on VA. The study by
Ozisik et al. identified that in the adult population, vaccination
was low for tetanus and influenza, but when doctors recom
mended the vaccine to the patients, they reacted positively to
vaccine acceptance and the rates of vaccinations increased.55
These results imply that the healthcare policymakers need to
convey the benefits of vaccines through health-care profes
sionals to increase VA. Similarly, there should also be con
certed efforts and campaigns in improving the image and
credibility of the health-care professionals so as to improve
VA rates. The policymakers also need to conduct campaigns to
reduce the safety concerns of individuals to enhance VA rates.

Limitations and future research
Most importantly, the findings of this study are specifically applic
able only to the university communities in the UAE and therefore
the findings of the study cannot be generalized to general popula
tion in other contexts. The researchers and policymakers in other
contexts may apply these findings with caution. With respect to
effect of attitudinal factors on VA, the PLS-SEM main effects
model suggests a R2 of .39, which means the variation in the
depedent variable, VA is explained by the independent variables
included in the study to the extent of only 39% suggesting 61%
variation was not explained by the independent variables included
in the study. There could be other factors not included in the
study that might possibly affect the VA. The future research could
possibly examine the effects of the pandemic-induced behavioral
constraints in the general population. Furthermore, effect of other
context-specific pandemic-induced behavioral constraints on VA
can be examined in future research. For example, effect of
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mandatory vaccination certificates for receiving certain govern
ment services on VA might be examined (Mills 2022 26). Future
research could also investigate the effects of availability of tele
health in COVID-19 vaccine acceptance.56 Regarding attitudinal
factors, future research could investigate the effects of perceived
self-efficacy about vaccines and perceived social cause of herd
immunity.

Conclusion
This study filled the research gap in COVID-19 vaccine
acceptance studies by comprehensively examining the fac
tors that impact VA among communities of different uni
versities in the UAE. The findings suggested that
demographic factors except education level played no
role in the VA in the UAE, which would require further
investigation in other countries. The COVID-19 pan
demic-induced behavioral constraints such as work from
home for the employees and online classes for the students
did not play a role in VA. Our study also found that
people with co-morbid diseases had less VA than the
people with no co-morbid diseases. This finding is highly
significant in the studies on COVID-19 VA, which needs
further investigation in other contexts. The findings on the
effect of attitudinal factors toward COVID-19 vaccine
contributes to the extant research by recognizing the
importance of increasing perceived benefits and reducing
safety concerns toward COVID-19 vaccine and improving
trust in health-care professionals in the acceptance of
COVID-19 vaccine. Furthermore, the study also found
that by enhancing the trust in health-care professionals,
the safety concerns toward COVID-19 vaccines could be
reduced.
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